Article Versions Notes

Chalumeau C, Carton M, Eeckhoutte A, Ballet S, Vincent-Salomon A, Vuagnat P, Bellesoeur A, Pierga J-Y, Stern M-H, Bidard F-C, et al. Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals. Cancers. 2022; 14(9):2114. https://doi.org/10.3390/cancers14092114

Chalumeau, Clelia, Matthieu Carton, Alexandre Eeckhoutte, Stelly Ballet, Anne Vincent-Salomon, Perrine Vuagnat, Audrey Bellesoeur, Jean-Yves Pierga, Marc-Henri Stern, Francois-Clement Bidard, and et al. 2022. "Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals" Cancers 14, no. 9: 2114. https://doi.org/10.3390/cancers14092114

Chalumeau, C., Carton, M., Eeckhoutte, A., Ballet, S., Vincent-Salomon, A., Vuagnat, P., Bellesoeur, A., Pierga, J. -Y., Stern, M. -H., Bidard, F. -C., & Lerebours, F. (2022). Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals. Cancers, 14(9), 2114. https://doi.org/10.3390/cancers14092114